All In Biotech

Free tool

FAERS Monitor: Tobi

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 050753 or its brand name (Tobi, Tobramycin). Reports on generic versions are filed under their own applications.

Reports

17,580

Serious

14,064

80% of reports

Hospitalization

8,271

Death reported

2,372

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • death1,343
  • infective pulmonary exacerbation of cystic fibrosis1,134
  • pneumonia1,109
  • dyspnoea1,049
  • off label use1,044
  • cystic fibrosis830
  • cough813
  • drug ineffective781
  • acute kidney injury712
  • infection675
  • condition aggravated639
  • hospitalisation604
  • pyrexia572
  • fatigue514
  • malaise472

Reports by year received

View as table
YearReports
200492
2005113
200692
2007146
2008117
2009132
2010193
2011716
2012685
2013720
2014786
20151,157
2016847
2017895
20181,449
20192,047
20201,652
20211,110
20221,045
2023881
20241,079
2025937
2026689

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,036,579 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
infective pulmonary exacerbation of cystic fibrosisSignal1,134314.5295.1280,483
cystic fibrosisSignal830210.8196.1147,198
infectionSignal6755.65.22,552
acute kidney injurySignal7125.65.22,684
hospitalisationSignal6044.74.41,772
pneumoniaSignal1,1094.13.92,637
coughSignal8133.53.21,446
condition aggravatedSignal6392.52.3590
dyspnoeaSignal1,0492.22.1720
pyrexia5722.01.8280
death1,3431.91.8561
off label use1,0441.41.3139
malaise4721.31.231
fatigue5140.80.730
drug ineffective7810.70.799

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.